[Federal Register Volume 62, Number 21 (Friday, January 31, 1997)]
[Notices]
[Page 4779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-2476]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute on Drug Abuse (NIDA) Special Emphasis Panel
meetings:
Purpose/Agenda: To evaluate and review grant applications and
contract proposals.
Name of Committee: NIDA Special Emphasis Panel.
Date: February 6, 1997.
Time: 9:00 a.m.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Mr. Eric Zatman, Contract Review Specialist,
Office of Extramural Program Review, National Institute on Drug
Abuse, 5600 Fishers Lane, Room 10-42, Telephone (301) 443-1644.
Name of Committee: NIDA Special Emphasis Panel.
Date: February 11, 1997.
Time: 1:00 p.m.
Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Gamil Debbas, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
Name of Committee: NIDA Special Emphasis Panel.
Date: February 13, 1997.
Time: 9:00 a.m.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: Mr. Eric Zatman, Contract Review Specialist,
Office of Extramural Program Review, National Institute on Drug
Abuse, 5600 Fishers Lane, Room 10-42, Telephone (301) 443-1644.
This notice is being published less than 15 days prior to the
meetings due to the urgent need to meet timing limitations imposed
by the review and funding cycle.
The meetings will be closed in accordance with provisions set
forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Scientist Development, Research Scientist Development,
and Research Scientist Awards; 93.278, Drug Abuse National Research
Service Awards for Research Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health.)
Dated: January 27, 1997.
Paula N. Hayes,
Acting Committee Management Officer, NIH.
[FR Doc. 97-2476 Filed 1-30-97; 8:45 am]
BILLING CODE 4140-01-M
